These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22108836)

  • 1. Prediction of individual response to heart failure therapy.
    Bax JJ; Delgado V
    Eur Heart J; 2012 Mar; 33(5):567-9. PubMed ID: 22108836
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.
    Paraskevaidis IA; Tsiapras D; Karavolias G; Adamopoulos S; Dodouras T; Cokkinos P; Kremastinos DT
    J Am Soc Echocardiogr; 2006 May; 19(5):529-35. PubMed ID: 16644436
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case].
    Cioffi G; Stefenelli C
    Ital Heart J Suppl; 2001 Jun; 2(6):668-72. PubMed ID: 11460842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model.
    Arimura T; Sato R; Machida N; Bando H; Zhan DY; Morimoto S; Tanaka R; Yamane Y; Bonne G; Kimura A
    J Am Coll Cardiol; 2010 Apr; 55(14):1503-5. PubMed ID: 20359603
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotics for left-ventricular impairment?
    Ezekowitz M
    Lancet; 1998 Jun; 351(9120):1904. PubMed ID: 9654255
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
    Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
    Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.
    Kühl U; Pauschinger M; Schwimmbeck PL; Seeberg B; Lober C; Noutsias M; Poller W; Schultheiss HP
    Circulation; 2003 Jun; 107(22):2793-8. PubMed ID: 12771005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM; Andreou C; Conrad CH; Colucci WS
    Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
    Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure].
    Anguita Sánchez M; Rodríguez Esteban M; Ojeda Pineda S; Ruiz Ortiz M; Romo Peña E; Mesa Rubio D; Vallés Belsué F
    Rev Esp Cardiol; 2004 Sep; 57(9):834-41. PubMed ID: 15373989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
    Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of chronic amiodarone therapy on left ventricular function in dilated cardiomyopathy studied by the new Doppler-index].
    Lengyel M
    Orv Hetil; 1998 May; 139(19):1147-51. PubMed ID: 9613163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of dilated cardiomyopathy in an adolescent with change of a failing highly active antiretroviral drug therapy.
    Aliku TO; Lubega S; Lwabi P
    Afr Health Sci; 2015 Mar; 15(1):288-92. PubMed ID: 25834562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible cardiomyopathy.
    Dhadke SV; Dhadke VN
    J Assoc Physicians India; 2006 Sep; 54():740-1. PubMed ID: 17212027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block?
    Filippatos G; Kremastinos DT
    Eur Heart J; 2007 May; 28(9):1170-1. PubMed ID: 17412729
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
    Birks EJ; George RS; Hedger M; Bahrami T; Wilton P; Bowles CT; Webb C; Bougard R; Amrani M; Yacoub MH; Dreyfus G; Khaghani A
    Circulation; 2011 Feb; 123(4):381-90. PubMed ID: 21242487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist as a key factor for heart self-restoration in a 20-year-old patient with severe left ventricular dysfunction: five-year echocardiographic observation.
    Kowalczuk-Wieteska A; Pacholewicz J; Zakliczyński M; Barańska-Kosakowska A; Zembala M
    Kardiol Pol; 2015; 73(9):783. PubMed ID: 26390234
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.
    Liu X; Gu X; Li Z; Li X; Li H; Chang J; Chen P; Jin J; Xi B; Chen D; Lai D; Graham RM; Zhou M
    J Am Coll Cardiol; 2006 Oct; 48(7):1438-47. PubMed ID: 17010808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of therapy with amiodarone on clinical, functional, and cardiac sympathetic innervation in patients with idiopathic dilated cardiomyopathy.
    Flotats A; Carrió I
    J Nucl Cardiol; 2004; 11(2):110-3. PubMed ID: 15052240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.